Microarray Analysis of the Global Alterations in the Gene Expression in the Placentas From Cigarette‐smoking Mothers

The effects of maternal cigarette smoking on the transcriptome of human full‐term placentas were investigated by a microarray analysis. QPCR was performed for a selected set of metabolizing genes. Differentially expressed genes were selected by fold change (±1.5‐fold) and analysis of variance (P<0.05) between the control and smoker groups. The expression of 174 probe sets was affected significantly. Chronic cigarette smoking induced the expression of CYP1A1. A trend toward a decrease in the expression of several steroid hormone‐metabolizing enzymes, including CYP19A1, was detected. The expression of phase II enzymes was not altered, and no enriched categories were observed among the regulated genes, except for aryl hydrocarbon receptor (AhR)‐CYP1A1. The unaltered expression of phase II enzymes may result in an increase in the levels of active metabolites and elevated oxidative chemical stress in the placenta and the fetus. On the basis of our results, it seems that cigarette smoke acts as a hormone disrupter in the placenta.

[1]  S. Fisher,et al.  The adverse effects of maternal smoking on the human placenta: a review. , 2005, Placenta.

[2]  The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[3]  E. Cavalieri,et al.  Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. , 2001, Metabolism: clinical and experimental.

[4]  J. Adamski,et al.  A guide to 17beta-hydroxysteroid dehydrogenases. , 2001, Molecular and cellular endocrinology.

[5]  E. Puhakainen,et al.  Assessment of the automated colorimetric and the high-performance liquid chromatographic methods for nicotine intake by urine samples of smokers' smoking low- and medium-yield cigarettes. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[6]  O. Vuolteenaho,et al.  Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. , 1997, Circulation research.

[7]  J. Hakkola,et al.  Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. , 1996, Biochemical pharmacology.

[8]  T. Saleh,et al.  Role of Polymorphic Human Cytochrome P450 Enzymes in Estrone Oxidation , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  P. Myllynen,et al.  The fate and effects of xenobiotics in human placenta , 2007, Expert opinion on drug metabolism & toxicology.

[10]  S. Curran,et al.  Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis , 2005, Clinical Cancer Research.

[11]  X. Coumoul,et al.  The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein , 2007, FEBS letters.

[12]  N. Bunce,et al.  Application of the ethoxyresorufin‐O‐deethylase (EROD) assay to mixtures of halogenated aromatic compounds , 2001, Environmental toxicology.

[13]  M. Laniado-Schwartzman,et al.  Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia , 2003, Journal of cellular biochemistry.

[14]  J. Liehr,et al.  Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[15]  T. Vartiainen,et al.  Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg. , 2000, Environmental research.

[16]  O. Pelkonen,et al.  Antepartum glucocorticoid therapy suppresses human placental xenobiotic and steroid metabolizing enzymes. , 2000, Placenta.

[17]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[18]  W. Baer-Dubowska,et al.  The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. , 2006, Toxicology letters.

[19]  K. Husgafvel‐Pursiainen,et al.  Identification of genetic polymorphisms of CYP2S1 in a Finnish Caucasian population. , 2004, Mutation research.

[20]  R. Sharpe.  The 'oestrogen hypothesis'- where do we stand now? , 2003, International journal of andrology.

[21]  Graeme I Murray,et al.  Profiling Cytochrome P450 Expression in Ovarian Cancer: Identification of Prognostic Markers , 2005, Clinical Cancer Research.

[22]  K. Bock,et al.  Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. , 2007, Biochemical pharmacology.

[23]  P. Brown,et al.  Gene expression patterns in human placenta. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Myatt,et al.  Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts. , 2003, Endocrinology.

[25]  K. Kostial,et al.  Placental cadmium and progesterone concentrations in cigarette smokers. , 2001, Reproductive toxicology.

[26]  A. Varvarigou,et al.  Increased cortisol concentrations in the cord blood of newborns whose mothers smoked during pregnancy , 2006, Journal of perinatal medicine.

[27]  Pasanen,et al.  The expression and regulation of drug metabolism in human placenta. , 1999, Advanced drug delivery reviews.

[28]  T. Aoyama,et al.  Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. , 1991, Archives of biochemistry and biophysics.

[29]  A Poland,et al.  An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1978, The Journal of pharmacology and experimental therapeutics.

[30]  T. Vartiainen,et al.  Selenium in pregnancy: is selenium an active defective ion against environmental chemical stress? , 2004, Environmental research.

[31]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[32]  J. Rysä,et al.  Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure , 2005, Hypertension.

[33]  R. Edwards,et al.  Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. , 1996, Biochemical pharmacology.

[34]  G. Murray,et al.  Profiling Cytochrome P 450 Expression in Ovarian Cancer : Identification of PrognosticMarkers , 2005 .

[35]  J. Olsen,et al.  Is prenatal exposure to tobacco smoking a cause of poor semen quality? A follow-up study. , 2007, American journal of epidemiology.

[36]  M. Llanos,et al.  Metals content in placentas from moderate cigarette consumers: correlation with newborn birth weight , 2005, Biometals.

[37]  R. Langley,et al.  Early postnatal exposure to cigarette smoke impairs the antigen-specific T-cell responses in the spleen. , 2006, Toxicology letters.

[38]  J. Mathis,et al.  Profiling transcript levels for steroidogenic enzymes in fetal tissues , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  O. Pelkonen,et al.  Xenobiotic and steroid-metabolizing monooxygenases catalysed by cytochrome P450 and glutathione S-transferase conjugations in the human placenta and their relationships to maternal cigarette smoking. , 1990, Placenta.

[40]  R. Mayer,et al.  Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. , 1985, Biochemical pharmacology.

[41]  J. Adamski,et al.  A guide to 17β-hydroxysteroid dehydrogenases , 2001, Molecular and Cellular Endocrinology.

[42]  M. Pasanen.  Human placental aromatase activity: use of a C18 reversed-phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. , 1985, Biological research in pregnancy and perinatology.

[43]  S. Schwartz,et al.  Risk of Testicular Germ Cell Cancer in Relation to Variation in Maternal and Offspring Cytochrome P450 Genes Involved in Catechol Estrogen Metabolism , 2005, Cancer Epidemiology Biomarkers & Prevention.

[44]  M. Pasanen,et al.  Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro. , 2000, Environmental health perspectives.

[45]  L. Tinelli.  [THE PLACENTA AS AN ENDOCRINE ORGAN]. , 1964, Minerva medica.

[46]  F. Labrie,et al.  Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. , 2006, Molecular endocrinology.

[47]  G. Perdew,et al.  A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins , 2002, Journal of biochemical and molecular toxicology.

[48]  H. Guan,et al.  Cadmium reduces 11-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells , 2005 .

[49]  Robert C. Wolpert,et al.  A Review of the , 1985 .